📰 Interventional Trial News
Interventional Trial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interventional Trial. Real-time updates on events, politics, business and more.
July 29, 2022
Publication of MERIT Study Follows FDA Market Authorization of Apollo ESGAUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive
May 18, 2022
AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced
October 22, 2021
Trial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health ConditionsMERIT-Trial met its primary endpoints for safety and efficacy,
October 7, 2021
Revenue expected between $16.0 million and $16.4 millionThird consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30%Submitted a De Novo 510(k) Classification Request to FDA
August 4, 2021
Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET ACCESSWIRE 04 Aug 2021, 06:05 GMT+10 AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2021. Highlights Achieved to...